UNVERIFIEDSingle SourceSTAT+: Drugmakers guard IP more tightly amid China competition Stat News|5/20/2026
UNVERIFIEDSingle SourceSingle-molecule tracker illuminates workings of cancer-related proteinsMIT News|5/19/2026
UNVERIFIEDSingle SourceSTAT+: A new ranking of pharma companies by R&D performance Stat News|5/19/2026
UNVERIFIEDSingle SourceSTAT+: Eli Lilly tops prominent rankings on pharma R&D performanceStat News|5/19/2026
UNVERIFIEDSingle SourceSTAT+: A political contest in the U.K. could shake up drug pricingStat News|5/15/2026
UNVERIFIEDSingle SourceSTAT+: Biogen’s tau-targeting Alzheimer’s drug posts mixed results in mid-stage studyStat News|5/14/2026
UNVERIFIEDSingle SourceSTAT+: CREATE Medicines, a biotech company developing CAR-T therapies, raises $122 millionStat News|5/14/2026
UNVERIFIEDSingle SourceSTAT+: Regenxbio says Duchenne gene therapy succeeded in clinical trial, paving way for FDA submissionStat News|5/14/2026
UNVERIFIEDSingle SourceSTAT+: ‘No drama’ Diamantas should serve biotech well as acting FDA chiefStat News|5/14/2026
UNVERIFIEDSingle SourceSTAT+: What the Trump administration wants in its next FDA leaderStat News|5/13/2026